RecoverPC: Relugolix vs GnRH Agonist in Quality of Life
RecoverPC: Relugolix vs GnRH Agonist in Quality of Life
Recruiting · NCT05765500 · Registry updated 2026-07-30Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| RecoverPC: Relugolix vs GnRH Agonist in Quality of Life | Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorder | Recruiting | Phase 2 | 2026-07-30 | NCT05765500 |
4 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Dana-Farber Cancer Institute | 324 |
| Pfizer | 431 |
| Prostate Cancer Foundation | 24 |
| Sumitomo Pharma America, Inc. | 16 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Brigham and Women's Hospital | Boston | United States | 60 |
| Dana-Farber Cancer Institute | Boston | United States | 626 |
| Dana-Farber Cancer Institute at Foxborough | Foxborough | United States | 17 |